Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.87M | 3.55M | 2.24M | -3.56M | -9.35M |
| Total Depreciation and Amortization | 6.54M | 6.56M | 6.60M | 6.45M | 6.28M |
| Total Amortization of Deferred Charges | 905.10K | 879.20K | 856.20K | 842.50K | 826.90K |
| Total Other Non-Cash Items | 758.30K | 742.10K | 714.40K | 11.65M | 22.55M |
| Change in Net Operating Assets | 3.35M | 3.35M | 3.35M | -6.98M | -17.30M |
| Cash from Operations | 16.42M | 15.07M | 13.76M | 8.40M | 3.01M |
| Capital Expenditure | -3.63M | -3.24M | -2.85M | -4.22M | -5.57M |
| Sale of Property, Plant, and Equipment | -1.46M | -1.45M | -1.44M | -721.20K | 4.80K |
| Cash Acquisitions | 393.00K | 393.00K | 393.00K | 197.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.21M | 3.86M | 4.51M | 3.89M | 3.26M |
| Cash from Investing | -1.48M | -440.50K | 609.10K | -855.60K | -2.31M |
| Total Debt Issued | 319.40M | 311.27M | 303.14M | 336.22M | 369.30M |
| Total Debt Repaid | -388.32M | -387.94M | -387.56M | -365.96M | -344.36M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.60M | -15.75M | -16.90M | -16.55M | -16.20M |
| Cash from Financing | -11.58M | -12.81M | -14.08M | -6.45M | 1.19M |
| Foreign Exchange rate Adjustments | 90.30K | 123.60K | 157.00K | 105.30K | 53.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.44M | 1.95M | 439.30K | 1.20M | 1.94M |